ROMAGNOLI, Dante
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.030
EU - Europa 2.065
AS - Asia 2.046
SA - Sud America 278
Continente sconosciuto - Info sul continente non disponibili 80
AF - Africa 56
OC - Oceania 29
Totale 9.584
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.926
SG - Singapore 664
CN - Cina 528
GB - Regno Unito 430
IT - Italia 404
PL - Polonia 239
HK - Hong Kong 219
DE - Germania 208
VN - Vietnam 207
BR - Brasile 201
FI - Finlandia 195
SE - Svezia 164
BD - Bangladesh 101
RU - Federazione Russa 99
FR - Francia 95
UA - Ucraina 63
IN - India 52
TR - Turchia 52
CA - Canada 46
ID - Indonesia 43
KR - Corea 35
BG - Bulgaria 31
AR - Argentina 30
JP - Giappone 29
AU - Australia 27
LT - Lituania 26
NL - Olanda 23
MX - Messico 20
IQ - Iraq 17
EG - Egitto 15
ZA - Sudafrica 15
PK - Pakistan 13
BE - Belgio 11
EC - Ecuador 11
ES - Italia 11
MY - Malesia 11
AT - Austria 10
GR - Grecia 10
CO - Colombia 9
IE - Irlanda 9
SA - Arabia Saudita 9
SI - Slovenia 8
PE - Perù 7
PH - Filippine 7
CZ - Repubblica Ceca 6
HN - Honduras 6
JM - Giamaica 6
JO - Giordania 6
MA - Marocco 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
BH - Bahrain 5
CR - Costa Rica 5
EU - Europa 5
GT - Guatemala 5
NP - Nepal 5
TH - Thailandia 5
UY - Uruguay 5
VE - Venezuela 5
CL - Cile 4
DZ - Algeria 4
SV - El Salvador 4
BB - Barbados 3
BO - Bolivia 3
CH - Svizzera 3
DK - Danimarca 3
ET - Etiopia 3
HU - Ungheria 3
IR - Iran 3
KE - Kenya 3
LB - Libano 3
OM - Oman 3
PY - Paraguay 3
TW - Taiwan 3
AZ - Azerbaigian 2
CI - Costa d'Avorio 2
GE - Georgia 2
KG - Kirghizistan 2
MN - Mongolia 2
NI - Nicaragua 2
PA - Panama 2
PT - Portogallo 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TJ - Tagikistan 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UG - Uganda 2
AL - Albania 1
BM - Bermuda 1
BY - Bielorussia 1
BZ - Belize 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GH - Ghana 1
HR - Croazia 1
KH - Cambogia 1
KZ - Kazakistan 1
Totale 9.499
Salva come PNG Salva come JPEG
Città #
Ashburn 542
Fairfield 505
Singapore 467
Santa Clara 400
Woodbridge 295
Chandler 252
Seattle 249
Southend 246
Houston 244
San Jose 242
Warsaw 237
Hong Kong 211
Wilmington 187
Helsinki 182
Council Bluffs 159
Cambridge 153
Dearborn 123
Nyköping 123
Ann Arbor 99
Hefei 94
New York 91
Modena 90
Beijing 86
London 86
Jacksonville 77
Los Angeles 61
Ho Chi Minh City 59
Hanoi 57
The Dalles 55
Chicago 39
Shanghai 39
Lauterbourg 36
San Diego 35
Milan 33
Seoul 33
Izmir 32
Sofia 29
Princeton 27
Jakarta 26
Boardman 25
Eugene 25
Moscow 25
Phoenix 22
Munich 21
Buffalo 20
Guangzhou 20
Frankfurt am Main 19
Melbourne 19
São Paulo 18
Dallas 17
Salt Lake City 16
Columbus 15
Tokyo 15
Atlanta 14
Denver 14
Redwood City 14
Rome 14
Bologna 13
Athens 12
Orem 12
Da Nang 11
Redondo Beach 11
Dong Ket 10
Fremont 10
San Mateo 10
Stockholm 10
Amsterdam 9
Bremen 9
Brussels 9
Chennai 9
Dublin 9
Florence 9
Johannesburg 9
Manchester 9
Naples 9
Schiffdorf 9
Toronto 9
Haiphong 8
Mexico City 8
Miano 8
Padova 8
Palisades Park 8
Boston 7
Carpi 7
Nanjing 7
Semarang 7
Amman 6
Brno 6
Dhaka 6
Kingston 6
Montreal 6
Nuremberg 6
Paris 6
Portsmouth 6
Shibīn al Kawm 6
Sunnyvale 6
Washington 6
Charlotte 5
Curitiba 5
Gifu 5
Totale 6.681
Salva come PNG Salva come JPEG
Nome #
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 505
Liver Angiopoietin-2 is a key predictor of de novo or recurrent hepatocellular cancer after HCV direct-acting antivirals 468
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis 402
NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk 393
Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis 391
Sofosbuvir-based therapy cures hepatitis C virus infection after prior treatment failures in a patient with concurrent lymphoma 378
Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease 357
Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis 355
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 352
Fatty liver is associated with an increased risk of diabetes and cardiovascular disease-Evidence from three different disease models: NAFLD, HCV and HIV 351
Nonalcoholic fatty liver disease and aging: epidemiology to management 339
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 330
Do Nonalcoholic Fatty Liver Disease and Fetuin-A Play Different Roles in Symptomatic Coronary Artery Disease and Peripheral Arterial Disease? 310
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 308
Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. 296
Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases 292
Pathogenesis and significance of hepatitis C virus steatosis: An update on survival strategy of a successful pathogen 289
Alcohol and Steatosis: The Japanese Paradox 282
Urology in the Time of Coronavirus: Reduced Access to Urgent and Emergent Urological Care during the Coronavirus Disease 2019 Outbreak in Italy 274
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 261
Nonalcoholic steatohepatitis heralding olmesartan-induced sprue-like enteropathy 257
Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation 251
Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications 243
Type 2 diabetes in non-alcoholic fatty liver disease and hepatitis c virus infection—liver: The “Musketeer” in the spotlight 242
Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma 228
Gender differences in chronic alcoholic and viral liver diseases 227
Do ultrasonographic semiquantitative indices predict histological changes in NASH irrespective of steatosis extent? 207
The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans 206
The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment 202
Long-Term SARS-CoV-2 Antibody Seroprevalence in Blood Donors, Italy 181
Dynamic Angiopoietin-2 Serum Level as Endothelial Damage Marker and Potential Therapeutic Target 178
Prognostic significance of hypoxic and metabolic gene profiling in hepatocellular carcinoma 168
Upregulation of the oestrogen target gene SIX1 is associated with higher growth speed and decreased survival in HCV-positive women with hepatocellular carcinoma 61
Totale 9.584
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.441
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.441
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022407 0 0 0 20 14 37 25 28 68 46 119 50
2022/2023683 68 90 61 77 66 76 15 72 75 9 32 42
2023/2024451 22 33 56 31 69 47 17 35 19 7 49 66
2024/20251.417 28 11 38 101 294 207 108 97 154 62 139 178
2025/20263.215 193 123 199 270 395 499 411 142 341 290 185 167
2026/2027572 103 181 190 98 0 0 0 0 0 0 0 0
Totale 9.584